The buccal drug delivery system global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Buccal Drug Delivery System Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The buccal drug delivery system market size has grown rapidly in recent years. It will grow from <b>$3.28 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. </b> The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.
The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to <b>$5.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. </b> The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Scope Of Buccal Drug Delivery System Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Buccal Drug Delivery System Market Overview
Market Drivers –
The rising prevalence of chronic diseases is expected to propel the growth of the buccal drug delivery systems market going forward. Chronic diseases refer to ailments that persist for a year or longer, such as cancer, heart disease, stroke, diabetes, cancer, and arthritis. These are the most prevalent chronic illnesses that can be managed but not cured and necessitate continuous nutrition and medical care. Buccal drug delivery systems provide appropriate and effective drug delivery for administering mucosal and transmucosal drugs that are required by several patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising prevalence of chronic diseases drives the growth of the buccal drug delivery systems market .
Market Trends –
Investments in injectable drug delivery systems are a key trend gaining popularity in the buccal drug delivery systems market. Major pharmaceutical companies are investing in drug delivery systems to sustain their position in the market. For instance, in September 2021, Novartis, a Switzerland-based pharmaceutical company, invested approximately $40 million in Credence MedSystems, a US-based company that develops innovative drug delivery systems. The aim of the investment is to boost the production of injectable drug delivery systems.
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cesstion, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Get an inside scoop of the buccal drug delivery system market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
Regional Insights –
North America was the largest region in the buccal drug delivery systems market share in 2023. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the buccal drug delivery system market report are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior plc, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca plc, F Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company plc, Reckitt Benckiser Group plc, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.
Table of Contents
1. Executive Summary
2. Buccal Drug Delivery System Market Report Structure
3. Buccal Drug Delivery System Market Trends And Strategies
4. Buccal Drug Delivery System Market – Macro Economic Scenario
5. Global Buccal Drug Delivery System Market Size and Growth
.
.
.
31. Global Buccal Drug Delivery System Market Competitive Benchmarking
32. Global Buccal Drug Delivery System Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market
34. Buccal Drug Delivery System Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
